Clinical Trials Logo

Other Solid Tumors clinical trials

View clinical trials related to Other Solid Tumors.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06358053 Not yet recruiting - Cervical Cancer Clinical Trials

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Start date: April 15, 2024
Phase: Phase 1
Study type: Interventional

A single center, open, single arm dose escalation and dose expansion phase I study to evaluate the safety, tolerability, and efficacy of CRTE7A2-01 TCR-T cells in HLA-A*02:01+ Subjects HPV16 positive advanced cervical, anal, or head and neck cancers. The study will determine RP2D of CRTE7A2-01 TCR-T cell injection.

NCT ID: NCT06027983 Not yet recruiting - Other Solid Tumors Clinical Trials

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

Start date: November 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This phase Ib study aims to assess the safety and feasibility of combination of chimeric receptor T cells with trastuzumab in patients with HER2+ solid tumors, with further expansion of study population in HER2+ metastatic breast cancer once safety has been established.

NCT ID: NCT05906524 Not yet recruiting - Other Solid Tumors Clinical Trials

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Start date: April 15, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1b/2, open label study to evaluate the safety, tolerability, pharmacokinetics and initial efficacy of KD6001 in combination with Tislelizumab ± Bevacizumab in patients with Advanced HCC and Other Solid Tumors.